The NASH PH2 trial is made up of two arms - 350mg open label and 700mg blinded. Publishing only the 350mg arm data and saying the trial met its end points is simply untrue. These are the kinds of claims the FDA frowned upon and the SEC and DOJ are looking into. Hence you will not find this anywhere on the CYDY website
The only thing funny with Cytodyn is how it always goes down after longs challenge each and every common sense assertion. Short sellers have been correct in each of these discussions. Not very funny it seems.